| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/13/2003 | WO2003020731A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 03/13/2003 | WO2003020282A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 03/13/2003 | WO2003020266A1 Antineoplastic combinations |
| 03/13/2003 | WO2002088080A3 Dual inhibitors of pde 7 and pde 4 |
| 03/13/2003 | WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 03/13/2003 | WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 03/13/2003 | US20030050300 Therapeutic 5-HT ligand compounds |
| 03/13/2003 | US20030050299 An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents |
| 03/13/2003 | US20030050255 An ophthalmic formulation containing an ascomycin and at least one polymer selected from ethylene oxide-propylene oxide copolymer and a crosslinked acrylic acid polymer |
| 03/13/2003 | US20030050222 Antineoplastic combinations |
| 03/13/2003 | CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 03/13/2003 | CA2458213A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 03/13/2003 | CA2455126A1 Antineoplastic combinations |
| 03/12/2003 | EP1289997A1 Macrolides |
| 03/12/2003 | EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 03/12/2003 | EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 03/12/2003 | EP1044203B1 3'-epimeric k-252a derivatives |
| 03/12/2003 | EP0763039B1 42-rapamycin hydroxyester, process for its preparation and pharmaceutical compositions containing it |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | CN1402731A Regioselective synthesis of rapamycin derivs. |
| 03/12/2003 | CN1102927C Prepn. of 1-butyl-4-piperidinylmethylamine |
| 03/11/2003 | US6531487 Water solubility; bioavailability |
| 03/11/2003 | US6531484 Viricides for preventing infection by HIV, treating infection by HIV, delaying of the onset of AIDS, or treating AIDS |
| 03/11/2003 | CA2262837C An asymmetric conjugate addition reaction |
| 03/07/2003 | WO2002020531A2 Method for producing anellated tetrahydro-[1h]-triazoles |
| 03/07/2003 | CA2421839A1 Method for producing anellated tetrahydro-[1h]-triazoles |
| 03/06/2003 | WO2003019697A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 03/06/2003 | WO2003018599A1 1-(2,5'-anhydro-lyxofuranosyl) thymines for the synthesis of radiomarked fluoro-3 deoxynucleotides |
| 03/06/2003 | WO2003018587A1 Helix mimetics and composition and methods related thereto |
| 03/06/2003 | WO2003018548A2 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof |
| 03/06/2003 | WO2003017990A2 Ophthalmic composition comprising an ascomycin |
| 03/06/2003 | US20030045710 Methods for identifying, obtaining and using new polyketide compounds |
| 03/06/2003 | US20030045545 Immunomodulators, induce cytokine biosynthesis, and antineoplastic agents |
| 03/06/2003 | US20030045520 Tricyclic compound having spiro union |
| 03/06/2003 | US20030045519 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 03/06/2003 | US20030044452 Composition for topical administration |
| 03/05/2003 | EP1287002A1 Crf receptor antagonists |
| 03/05/2003 | EP0690863B1 Tetracyclic compounds as dopamine agonists |
| 03/05/2003 | CN1400969A Fused imidazolium derivatives |
| 03/04/2003 | US6528534 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 03/04/2003 | US6528517 Solid phase synthesis |
| 02/27/2003 | WO2003016316A1 Diazacycloalkanes as oxytocin agonists |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003016248A2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
| 02/27/2003 | WO2003016245A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 02/27/2003 | WO2003015780A2 Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 02/27/2003 | WO2003015517A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/27/2003 | WO2003004098A8 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 02/27/2003 | WO2002092010A3 Reverse-turn mimetics and methods relating thereto |
| 02/27/2003 | WO2002088141A3 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-2,6,9-TRIOXA-3-AZA-CYCLOPENTA[a]NAPHTHALENE |
| 02/27/2003 | WO2002067675A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 02/27/2003 | WO2002028865A3 Condensed pyridoindole derivatives |
| 02/27/2003 | US20030040623 For use in synthetic resins to obtain violet to blue tints; used in phototropic glasses |
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/27/2003 | CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/27/2003 | CA2454762A1 Isoxazolopyridinones |
| 02/27/2003 | CA2453962A1 Diazacycloalkanes as oxytocin agonists |
| 02/26/2003 | EP1284978A1 Process for the purification of a salt of clavulanic acid |
| 02/26/2003 | EP1216251B1 Regioselective synthesis of rapamycin derivatives |
| 02/26/2003 | EP1011726B1 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 02/26/2003 | EP0754040B1 Rapamycin derivatives |
| 02/26/2003 | CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 02/25/2003 | US6525075 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene |
| 02/25/2003 | US6525067 Substituted heterocyclic derivatives |
| 02/25/2003 | US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 02/25/2003 | US6525000 N-aminoureas are reacted with formaldehyde to give methyleneimino ureas, cyclizing these to give tetrahydro-4H-1,3,4-oxa(or thia)diazines, and cyclizing the fused triazoles using phosgene; herbicides |
| 02/25/2003 | US6524556 Tricyclic compound dispersed in liquefied hydrofluoroalkane propellant; medium-chain fatty acid triglyceride as dispersant |
| 02/20/2003 | WO2003014125A1 Therapeutically useful tetracyclic ligands |
| 02/20/2003 | WO2003014121A1 Compounds, derivatives, compositions, preparation and uses |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | CA2453219A1 Therapeutically useful tetracyclic ligands |
| 02/19/2003 | EP0981530B1 Compounds on the basis of polyalkyl-1-oxa-diazaspirodecane compounds |
| 02/19/2003 | EP0931083B1 Process for producing ecteinascidin compounds |
| 02/19/2003 | EP0920429B1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 02/19/2003 | EP0750618B1 Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 02/18/2003 | US6521630 Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/13/2003 | WO2003011870A1 Gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011298A1 Antibacterial oxazinones and methods for their use and synthesis |
| 02/13/2003 | WO2003011222A2 Thrombin inhibitors |
| 02/13/2003 | US20030033089 Substituted quinazolines and analogs and the use thereof |
| 02/13/2003 | US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds |
| 02/13/2003 | US20030032640 Novel composition |
| 02/12/2003 | EP1283205A1 Naphthol derivatives |
| 02/12/2003 | EP1282626A2 Polyketide derivatives |
| 02/12/2003 | EP1282625A1 Benzoxazines for use in the treatment of parkinson's disease |
| 02/12/2003 | EP1282624A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282622A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282621A1 Novel vitronectin receptor antagonists |
| 02/12/2003 | EP1282618A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/11/2003 | CA2043229C Pyrido[3,4-b]pyrrolo[1,2-e] [1,4,5]oxadiazepines and related analogs, a process for their preparation and their use as medicaments |
| 02/11/2003 | CA2030715C Hexahydro-1h-quino¬4,3,2-ef|¬1,4|benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments |
| 02/06/2003 | WO2003010158A1 Novel compounds |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003000256A9 Substituted oxazolidinones for combinational therapy |